Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway
QianYu Lu, LiJiao Yang, Jing‐Jie Xiao, Qing Liu, Lihua Ni, Junwei Hu, Hong Yu, Xiaoyan Wu, Baifang Zhang
Topics & Concepts
EmpagliflozinLipid peroxidationGPX4MalondialdehydeAMPKOxidative stressChemistryKidneyDiabetes mellitusApoptosisPharmacologyMedicineCancer researchGlutathione peroxidaseInternal medicineEndocrinologySuperoxide dismutaseType 2 diabetesBiochemistryKinaseProtein kinase AFerroptosis and cancer prognosisEpigenetics and DNA MethylationCancer-related molecular mechanisms research